Biernacki M et al. |
Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma. |
2018 |
Prostaglandins Other Lipid Mediat. |
pmid:30201316
|
Hillard CJ |
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785538
|
Avraham Y et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. |
2008 Jul-Aug |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:18771906
|
Sugiura T et al. |
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052034
|
Fowler CJ and Jacobsson SO |
Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052035
|
Högestätt ED and Zygmunt PM |
Cardiovascular pharmacology of anandamide. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052048
|
Watanabe S et al. |
n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. |
2003 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12878451
|
Matias I et al. |
Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. |
2006 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:17011761
|
Iannotti FA et al. |
Analysis of the "endocannabinoidome" in peripheral tissues of obese Zucker rats. |
2013 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:23830028
|
Yi B et al. |
Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors. |
2016 |
Prog. Neuropsychopharmacol. Biol. Psychiatry |
pmid:26780604
|
Bystrowska B et al. |
Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training. |
2014 |
Prog. Neuropsychopharmacol. Biol. Psychiatry |
pmid:24334211
|
Gould GG et al. |
Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. |
2012 |
Prog. Neuropsychopharmacol. Biol. Psychiatry |
pmid:22542870
|
Baggelaar MP et al. |
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain. |
2018 |
Prog. Lipid Res. |
pmid:29751000
|
Iannotti FA et al. |
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders. |
2016 |
Prog. Lipid Res. |
pmid:26965148
|
Sugiura T et al. |
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2006 |
Prog. Lipid Res. |
pmid:16678907
|
Calignano A et al. |
A role for the endogenous cannabinoid system in the peripheral control of pain initiation. |
2000 |
Prog. Brain Res. |
pmid:11098711
|
Haj-Dahmane S et al. |
Fatty-acid-binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses. |
2018 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:29531087
|
Adermark L and Lovinger DM |
Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step. |
2007 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:18077376
|
Keimpema E et al. |
Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:23319656
|
Alhouayek M et al. |
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24101490
|